Physicochemical characterization of anionic lipid-based ternary siRNA complexes  by Kapoor, Mamta & Burgess, Diane J.
Biochimica et Biophysica Acta 1818 (2012) 1603–1612
Contents lists available at SciVerse ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbamemPhysicochemical characterization of anionic lipid-based ternary siRNA complexes
Mamta Kapoor, Diane J. Burgess ⁎
Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, 69 N Eagleville Rd, Unit 3092, Storrs, CT 06269, USA⁎ Corresponding author. Tel.: +1 860 486 3760; fax:
E-mail address: d.burgess@uconn.edu (D.J. Burgess)
0005-2736/$ – see front matter. Published by Elsevier B
doi:10.1016/j.bbamem.2012.03.013a b s t r a c ta r t i c l e i n f oArticle history:
Received 13 January 2012
Received in revised form 13 March 2012
Accepted 14 March 2012
Available online 21 March 2012
Keywords:
Physicochemical characterization
Anionic lipoplex
siRNA delivery
Lipoplex morphology
Silencing efﬁciency
Loading efﬁciencyPhysicochemical characterization is a useful tool in understanding lipoplex assemblies and their correlation
to biological activity. Anionic lipid-based ternary siRNA complexes composed of anionic liposomes (DOPG/
DOPE), calcium ions and siRNA, have recently been shown to be safe and efﬁcient in a breast cancer cell cul-
ture model. In the present work, the effects of various formulation parameters such as liposome composition
(DOPG/DOPE ratio) and anionic lipid/Ca2+/siRNA molar charge ratio, on the physicochemical attributes (par-
ticle size, surface charge, siRNA loading efﬁciency and serum stability) of these ternary anionic lipoplexes
were evaluated. Particle size, siRNA loading efﬁciency and serum stability correlated with the in vitro silenc-
ing efﬁciency of these lipoplexes. For example, large lipoplex particles (5/2.5/1 anionic lipid/Ca2+/siRNA
molar charge ratio) showed less efﬁcient silencing while absolute serum stability and high siRNA loading
(1.3/2.5/1 anionic lipid/Ca2+/siRNA molar charge ratio), exhibited maximum silencing in breast cancer
cells. The physicochemical properties also indicated that the siRNA exists in the complexed and/or encapsu-
lated form within the lipoplexes, depending on the anionic lipid/siRNA charge ratio. Based on these studies a
model representing lipid–siRNA association within the anionic lipoplexes prepared under various formula-
tion conditions is proposed. Physicochemical attributes can be utilized to estimate in vitro activity of lipid–
siRNA complexes and understand their morphology.
Published by Elsevier B.V.1. Introduction
Small interfering RNA (siRNA) therapeutics show great promise for
treatment of several ‘undruggable’ targets such as Huntington's dis-
ease [1], TTR amyloidosis [2] and respiratory synctial virus [3]. The
rapid development in this ﬁeld is evident by the number of potential
products in clinical trials within only a decade of siRNA discovery
[4]. siRNA has several advantages over other nucleic acid therapies
such as its high potency, high speciﬁcity and no constraint for nuclear
delivery. Unfortunately, like other nucleic acids, effective delivery of
siRNA is a critical issue. This is due to its susceptibility to enzymatic
degradation, low cellular uptake and endosomal escape [5]. Several
non-viral delivery vectors have been utilized to resolve these issues
[6,7], such as liposomes, which facilitate efﬁcient cellular uptake, ef-
fective endosomal release of siRNA and protect siRNA against enzy-
matic attack [8]. There are several lipid based delivery systems
currently employed in clinical trials for siRNAmolecules [4,9]. A num-
ber of cationic liposomes that electrostatically interact with siRNA,
have been employed to achieve efﬁcient siRNA delivery both in vitro
and in vivo [4]. However, cationic lipid formulations are inactive in
serum and result in severe cytotoxicity [10–14]. For these reasons, an-
ionic lipid formulations are preferred [15,16]. Anionic lipid based+1 860 486 0538.
.
.V.systems, composed of anionic liposomes, Ca2+ ions and siRNA,
which show safe and efﬁcient delivery of siRNAhave recently been de-
veloped [17].
Despite the extensive use of liposomes for nucleic acid delivery,
there are no ofﬁcial FDA guidelines (only a draft form exists [18])
that can ensure robust product development strategies for such lipo-
somal products. With Quality by Design principles gaining popularity,
development of well characterized liposome based siRNA delivery
systems is imperative in order to facilitate rapid product develop-
ment and ensure product reproducibility. Consistent product perfor-
mance is critical speciﬁcally for siRNA products in clinical trials. Due
to the increasing number of liposome siRNA formulations entering
into clinical trials, there is a need for methodological evaluation of
physicochemical attributes of lipid-based siRNA formulations. Such
systematic studies can help elucidate the relationship between phys-
icochemical properties and biological activity [4] since it has been ob-
served that formulation parameters of lipoplex assemblies indirectly
affect biological activity due to their impact on the physicochemical
properties of the formulations [19–22]. Accordingly, there can be fas-
ter optimization of formulations for effective delivery, consequently
saving both time and resources. This is important for cost-effective
production of siRNA formulations on a commercial scale. Physico-
chemical characterization also facilitates thorough understanding of
factors affecting the association of lipoplex formulation components.
This can help in building a formulation and processing design space.
Additionally, a deeper understanding can be obtained regarding the
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formulation parameters.
Relative to DNA lipoplexes [16,21–33], there are very few reports
on comprehensive characterization of siRNA lipoplexes [34,35]. Addi-
tionally, these studies are based on two-component systems (lipids
and nucleic acids). In the present work, detailed physicochemical
characterization of a three-component system (anionic lipid-based
ternary complexes) was performed. The effects of various formula-
tion parameters (liposome composition and anionic lipid/Ca2+/
siRNA molar charge ratios) on particle properties were evaluated.
These results were utilized to understand the morphology of the an-
ionic siRNA lipoplexes as well as correlation of particle properties to
the silencing efﬁciency. A model has been proposed describing the as-
sociation of formulation components (lipid, Ca2+, siRNA) within the
novel anionic-siRNA lipoplex assemblies and how this changes with
formulation composition.
2. Materials and methods
2.1. Materials
The lipids DOPG (1,2-dioleoyl-sn-glycero-3-phospho-(1′-rac-
glycerol) and DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine)
were purchased from Avanti polar lipids Inc. (Alabama, USA). Anti-
eGFP (enhanced green ﬂuorescent protein) siRNA (Silencer® GFP
siRNA) and nuclease free water were obtained from Ambion (Austin,
TX). Calcium chloride, disodium EDTA (ethylenediamine tetra-acetic
acid), triton X-100 (TX-100) and HEPES buffer were purchased from
Sigma. For cell culture, MDA-MB-231 cells (breast cancer) stably trans-
fected with eGFP were purchased from Cell Biolabs (Cell Biolabs Inc.,
CA). Dulbecco'Modiﬁed Eagle'smedium (DMEM),Modiﬁed Eagle'sme-
dium–non essential amino acids (MEM–NEAA), Hank's balanced salt
solution (HBSS), Opti-MEM I, L-glutamine, heat inactivated fetal bovine
serum (FBS) and Quant-IT Ribogreen intercalation assay kit were
obtained from Invitrogen (Carlsbag, CA, USA). Penicillin–streptomycin
solution was purchased fromATCC (American Type Culture Collection).
2.2. Liposome and lipoplex preparation
For preparation of anionic liposomes, with various anionic to fuso-
genic lipid ratios (DOPG/DOPEmolar ratio), appropriate volume of lipids
(25 mg/mL stock solution in chloroform), was added to clean scintilla-
tion vials and dried using nitrogen ﬂux to form a thin ﬁlm. Residual sol-
vent was removed by overnight vacuum-desiccation. The formed lipid
ﬁlm was hydrated using 10 mM HEPES buffer, pH 7.4 for 1 h at 37 °C in
water bath. This was followed by 30 s vortexing and extrusion (Lipex™
extruder) to form unilamellar vesicles of size ca. 100 nm. The prepared
anionic liposomes (5 mg/mL stock solution) were mixed appropriately
with siRNA (50 μM stock solution) and Ca2+ ions (4.3 M CaCl2 stock so-
lution), for 15 min to obtain lipoplexes with desired anionic lipid/Ca2+/
siRNA molar charge ratio. For the purpose of lipoplex preparation, the
siRNA concentration was ﬁxed and the concentrations of lipid and calci-
umwere varied. The controls, Ca2+-siRNA complexes and lipid+siRNA
mixtures, were prepared similarly except for the addition of lipid and
calcium, respectively.
2.3. Particle size analysis
The hydrodynamic size of the particles was measured by dynamic
light scattering using a Malvern Zetasizer ZS90 with Zetasizer soft-
ware at 25 °C. For these studies, lipoplexes were prepared with
50 nM siRNA (100 μL volume) in 10 mM HEPES buffer, pH 7.4. The
particle size of the lipoplexes and liposomes was measured in tripli-
cate with at least 12 runs for each measurement. Results were
reported in terms of the intensity distribution.2.4. Zeta potential studies
The zeta potential of the anionic liposomes and the lipoplexes
was measured by Laser Doppler Velocimetry (LDV) using a Malvern
Zetasizer ZS90. The lipoplexes were prepared in 10 mM HEPES buffer
with 50 nM siRNA and the net surface charge was measured using a
universal ‘dip’ cell (Malvern, volume 1 mL). Samples were prepared
and evaluated in triplicate.
2.5. siRNA loading efﬁciency
Ribogreen assay was used to determine the siRNA loading efﬁcien-
cy using the manufacturer's protocol (Invitrogen). This assay is based
on the strong ﬂuorescence of ribogreen upon intercalation with
siRNA. For this assay, anionic lipoplexes were prepared with various
anionic lipid/Ca2+/siRNA molar charge ratios (10 nM siRNA, 100 μL
volume) in black 96 well plates (BD Optilux, Perkin Elmer). This
was followed by addition of either disodium EDTA (ﬁnal concen-
tration 2.5 mM) alone or a mixture of disodium EDTA and TX-100
(ﬁnal concentration 0.5% v/v) to the lipoplexes. (EDTA chelates diva-
lent ions e.g. Ca2+, TX-100 is a nonionic surfactant that solubilizes the
liposomes). After 5 min incubation, ribogreen was added to the sam-
ples (1:2 v/v) for another 2–4 min at room temperature. Following
this, the ribogreen ﬂuorescence was measured. Fluorescence was
also determined for anionic lipoplexes that were not treated with ei-
ther one (disodium EDTA) or both the reagents (disodium EDTA and
TX-100). A Spectramax Gemini XPS spectroﬂuorimeter (Molecular
Probes) at λex=490 nm, λem=520 nm, was used to conduct the
measurements. The free siRNA concentration was obtained from sam-
ple ﬂuorescence in the absence of both reagents, whereas the total
siRNA concentration was determined from sample ﬂuorescence in
the presence of both reagents. siRNA concentrations were obtained
from the ﬂuorescence using a standard curve prepared with standard
siRNA solution. Liposomes alone, siRNA alone, Ca2+–siRNA com-
plexes, lipid+siRNA mixtures and blanks (no lipid, Ca2+ or siRNA)
were used as controls. The ﬂuorescence of ‘liposomes alone’ was sub-
tracted from that of anionic lipoplexes and lipid+siRNA mixtures (at
corresponding lipid concentration) to account for any probable con-
tribution from the liposomes. The results were obtained from three
independent experiments (n=3). The percentage siRNA loading efﬁ-
ciency was calculated using the following formula:
% siRNA loading efficiency ¼100−½ Free siRNA concentrationð Þ
100= Total siRNA concentrationð Þ:
The percentage siRNA released from lipoplexes in the presence of
either disodium EDTA alone or both the reagents was also evaluated.
For these studies, the initial siRNA concentration was considered as
100%.
2.6. Serum stability studies
The stability of the lipoplexes prepared with various anionic lipid/
Ca2+/siRNA molar charge ratios, was evaluated in the presence of
10% serum using Ribogreen assay (Invitrogen). The lipoplexes were
incubated in DMEM (no phenol red) with 10% FBS for 4 h at 37 °C.
At various time points (0–4 h) an aliquot of the lipoplexes in serum
was withdrawn, diluted with 1× TE (Tris-EDTA, pH 7.8) buffer and
analyzed with ribogreen reagent. Fluorescence from ribogreen inter-
calation was measured using a spectroﬂuorimeter (λex=490 nm,
λem=520 nm). Uncomplexed siRNA in the lipoplexes at ‘time 0’
was subtracted from the siRNA released at ‘time t’ to account solely
for released siRNA due to serum. The percentage siRNA released
was obtained by considering the concentration of ‘siRNA only’ as
100%. Ca2+-siRNA complexes, lipid+siRNA mixtures, siRNA only
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with 10 nM siRNA and evaluated in triplicate in two independent ex-
periments (n=6).
2.7. Cell culture
Breast cancer cells (MDA-MB-231) stably transfected with eGFP
were utilized. The cells were cultured in DMEM with 10% FBS, 0.1 mM
MEM-NEAA, 2 m L-glutamine and 1% antibiotic mixture (penicillin–
streptomycin). The cells were incubated at 37 °C in 5% CO2 atmosphere.
Media was changed once every 2–3 days.
2.8. Silencing efﬁciency studies
One day before transfection, the cells were plated at 5×103 cells per
well in 100 μL culture media without antibiotics in black 96 well plates.
On the following day, the cells were transfectedwith 50 μL anionic lipo-
plexes prepared with 10 nM siRNA in Opti-MEM I media. 48 h post-
transfection, media was aspirated and the cells were washed twice
with 1× HBSS buffer. The buffer was aspirated and replaced with
100 μL fresh HBSS buffer. GFP expression readout was obtained using
a microplate spectroﬂuorimeter at λex=488 nm, λem=525 nm. The
readout was normalized for protein content (μg) using a standard BCA
assay (Pierce). The percentage GFP expression was obtained by consid-
ering untreated cells as 100%. Silencing efﬁciency was obtained by sub-
tracting the % GFP expression of treated cells from the % GFP expression
from the untreated cells (100%). The resultswere obtained from two in-
dependent experiments performed on different days and each day the
experiment was performed in triplicate (n=6). Untreated cells, siRNA
only, lipid+siRNA mixtures and Ca2+–siRNA complexes were used as
controls.
2.9. Statistics
For comparison between many groups, one-way ANOVA (analysis
of variance) with Tukey's post-test was performed using GraphPad
Prism software (version 5.0). For comparison of several groups with0
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Fig. 1. Particle size analysis of: (a) anionic liposomes prepared with different liposome comp
sitions at anionic lipid/Ca2+/siRNA molar charge ratio of 1.3/2.5/1; (c) anionic lipoplexes co
ratio of 1.3/1); (d) anionic lipoplexes prepared with different anionic lipid/siRNA molar ch
(dotted line) (Ca2+/siRNA molar charge ratio of 2.5/1) and anionic lipoplexes (solid line)
the control groups. *pb0.05, **pb0.01, and ***pb0.001. Mean±SD.a control group, one-way ANOVA with Dunnett's post-test was used.
For comparison of two samples at a time, student t-test was utilized.
3. Results
3.1. Particle size analysis
3.1.1. Effect of liposome composition on particle size
Liposomes were prepared with 10:90 DOPG/DOPE molar ratio
(10 mol% DOPG) to 80:20 DOPG/DOPE molar ratio (80 mol% DOPG).
The particle size of the anionic liposomes decreased with increase in
mol% DOPG (Fig. 1a). On the other hand, the particle size of the anionic
lipoplexes (anionic lipid/Ca2+/siRNA molar charge ratio of 1.3/2.5/1)
was not affected by change in the liposome composition (Fig. 1b).
The average particle size of the lipoplexes (344.0±9.8 nm) was ap-
proximately three times that of the liposomes (106.9±3.7 nm).
3.1.2. Effect of Ca2+/siRNA molar charge ratio on particle size
Based on the Ca2+/siRNA molar charge ratio, the particle size of
the lipoplexes (40 mol% DOPG, 1.3/1 lipid to siRNA molar charge
ratio) varied from 100 nm to 400 nm. The particles were ca. 100 nm
at the Ca2+/siRNA molar charge ratio of 0.6/1. However, the size in-
creased signiﬁcantly at higher charge ratios (Fig. 1c). Lipoplexes
were ca. 300 nm in size at a charge ratio of 2.5/1 and 400 nm in size
at a charge ratio of 5/1. Beyond this charge ratio there was no further
increase in particle size even up to a Ca2+/siRNAmolar charge ratio of
160/1.
3.1.3. Effect of anionic lipid/siRNA molar charge ratio on particle size
The particle size of lipoplexes prepared with various anionic lipid/
siRNA molar charge ratios (40 mol% DOPG, 2.5/1 Ca2+/siRNA molar
charge ratio) was evaluated. As shown in Fig. 1d, at low anionic
lipid/siRNA molar charge ratios (0.6/1 to 2.5/1), the lipoplexes were
ca. 350 nm in size. Further increase in anionic lipid/siRNA molar
charge ratios consistently increased the particle size to ca. 600 nm
at a charge ratio of 10/1, and even higher to ca. 1200 nm at a charge100
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aggregates with a polydispersity index of 0.9 (Fig. 1e).3.2. Zeta potential studies
3.2.1. Effect of liposome composition on zeta potential
The zeta potential of the liposomes prepared with various anionic
lipid/fusogenic lipid (DOPG/DOPE) ratios (or various mol% DOPG)
was evaluated. As expected, the anionic liposomes had a negative sur-
face charge (average −49.9±6.8 mV). The liposome surface charge
increased with increase in mol% of the anionic lipid, DOPG (Fig. 2a).
This trend was also evident in the case of lipoplexes that were formed
after the addition of Ca2+ ions and siRNA to anionic liposomes
(anionic lipid/Ca2+/siRNA molar charge ratio of 1.3/2.5/1) (Fig. 2b).
The addition of Ca2+ and siRNA reduced the surface charge from
−49.9±6.8 mV to −22.0±5.0 mV (average) indicating partial
charge neutralization of the liposomes upon lipoplex formation.3.2.2. Effect of Ca2+/siRNA molar charge ratio on zeta potential
At a Ca2+/siRNA molar charge ratio of 0.6/1 (40 mol% DOPG, an-
ionic lipid/siRNA molar charge ratio of 1.3/1), the zeta potential mea-
surements indicated a reduction in the liposome surface charge
(40 mol% DOPG) from −47.7±0.9 mV (no calcium) to ca. −15 mV
(Fig. 2c). Further increase in the Ca2+/siRNA molar charge ratio to
2.5/1, increased the charge to −22.9±0.6 mV. Additional increase
in the Ca2+/siRNA molar charge ratio continuously reduced the
charge towards zero and at a 160/1 Ca2+/siRNA molar charge ratio
the lipoplexes had a positive surface charge.3.2.3. Effect of anionic lipid/siRNA molar charge ratio on zeta potential
Increase in the anionic lipid/siRNA molar charge ratio from 0.6/1
to 5/1 (40 mol% DOPG, Ca2+/siRNA molar charge ratio of 2.5/1), in-
creased the zeta potential values from −18.3±0.8 mV to −28.7±
0.7 mV (Fig. 2d). Any further increase in the anionic lipid/siRNA
molar charge ratio did not signiﬁcantly affect the surface charge.-55
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Fig. 2. Zeta potential studies of: (a) anionic liposomes prepared with different liposome com
sitions at an anionic lipid/Ca2+/siRNA molar charge ratio of 1.3/2.5/1; (c) lipoplexes prepare
of 1.3/1); and (d) lipoplexes prepared with different anionic lipid/siRNA molar charge ratios
*pb0.05, **pb0.01, and ***pb0.001. Mean±SD.3.3. siRNA loading efﬁciency
3.3.1. Effect of Ca2+/siRNA molar charge ratio on loading efﬁciency
In the absence of lipids (Ca2+–siRNA complexes), siRNA loading
was negligible up to a Ca2+/siRNA molar charge ratio of 0.6/1
(Fig. 3a). However, at higher Ca2+/siRNAmolar charge ratios, the load-
ing efﬁciency increased signiﬁcantly to 80% at a charge ratio of 0.9/1 and
100% at a charge ratio of 2.5/1. These results indicated that complete
loading was achieved at a Ca2+/siRNA molar charge ratio of 2.5/1.
3.3.2. Effect of anionic lipid/siRNA molar charge ratio on loading
efﬁciency
At a low anionic lipid/siRNAmolar charge ratio (up to 5/1), minimal
siRNA was loaded into the lipoplexes (40 mol% DOPG) with Ca2+/
siRNAb0.6/1 (Fig. 3a). However, within the same range of Ca2+/
siRNA molar charge ratios, the loading efﬁciency increased with in-
crease in the anionic lipid/siRNA molar charge ratio. There was 20%
loading at a 10/1 ratio that increased to 60% at a 40/1 anionic lipid/
siRNA molar charge ratio. This increase in loading efﬁciency was also
evident in the case of lipid+siRNA mixtures (no calcium) (Fig. 3a,
Table 1). However, even at a very high anionic lipid/siRNAmolar charge
ratio (40/1), complete loading was not achieved at Ca2+/siRNA molar
charge ratios≤0.6/1.
In order to understand the nature of the association between
siRNA and the other components of the lipoplexes (lipid and Ca2+),
the percentage siRNA released from the anionic lipoplexes, when
treated with one or both reagents (2.5 mM disodium EDTA, 0.5%
TX-100), was determined. As indicated in Fig. 3b, when lipoplexes
were treated with EDTA alone, the % siRNA release decreased with in-
crease in the anionic lipid/siRNA molar charge ratio (Ca2+/siRNA
ratio of 2.5/1). On the contrary, 100% siRNA was released when the
lipoplexes were treated with both reagents (disodium EDTA+TX-
100), irrespective of the anionic lipid/siRNA molar charge ratio. For
example, at an anionic lipid/siRNA molar charge ratio of 40/1, 40%
siRNA was released with disodium EDTA alone, whereas it was 100%
in the presence of both disodium EDTA and TX-100. It must be
noted that in calculating % siRNA release, we have considered initial
siRNA concentration (used for sample preparation) as 100% (see10 20 40 60 80
Mol% DOPG
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siRNA release from anionic lipoplexes treated with TX100+EDTA
(at all lipid/siRNA ratios) indicates that complete siRNA recovery
was achieved with all the anionic formulations.
In the case of the controls, complete siRNA was released when the
Ca2+–siRNA complexes were treated with disodium EDTA alone.
Conversely, complete siRNA was released (no loaded siRNA) when
lipid+siRNA mixtures (no calcium) were treated with a combination
of reagents (TX-100+disodium EDTA) but not with disodium EDTA
alone (Fig. 3c).
3.4. Serum stability
3.4.1. Effect of Ca2+/siRNA molar charge ratio on serum stability
Complex stability of the Ca2+–siRNA complexes was evaluated in
media containing serum for 4 h at 37 °C. As shown in Fig. 4a, at a low
Ca2+/siRNA molar charge ratio of 0.9/1, 40% siRNA was released in
1 h and this increased to 75% in 3 h followed by no further release.
However, at higher Ca2+/siRNA molar charge ratios (1.3/1) both the
rate and extent of released siRNA decreased signiﬁcantly. There wasTable 1
Encapsulated and complexed siRNA in anionic lipoplexes (Ca2+/siRNA molar charge
ratio of 2.5/1) and lipid+siRNA mixtures (no calcium) prepared at various anionic
lipid/siRNA molar charge ratios.
Lipid/siRNA
ratio (m/m)
% siRNA
Anionic lipoplexes (Lipid+siRNA) mixtures
Encapsulated Complexed Encapsulated Complexed
1.3/1 0 100 0 0
5/1 10 90 10 0
10/1 20 80 20 0
20/1 40 60 40 0
40/1 60 40 60 0only 20% release in the initial two hours followed by saturation.
There was no release of siRNA at a Ca2+/siRNA molar charge ratio
of 2.5/1 indicating complete serum stability at this ratio. siRNA
alone did not degrade in 4 h.
3.4.2. Effect of anionic lipid/siRNA molar charge ratio on serum stability
At an anionic lipid/siRNA molar charge ratio of 1.3/1 (40 mol%
DOPG), lipoplexes showed a reduced rate and extent of siRNA re-
lease when compared to Ca2+–siRNA complexes (Ca2+/siRNA molar
charge ratiob2.5/1) (Fig. 4b). This protection of the complexes against
serum dissociation increased with increase in the anionic lipid/siRNA
molar charge ratio as indicated in Fig. 4c. However, complete serum
stabilitywas not achieved even at anionic lipid/siRNAmolar charge ra-
tios of 10/1 until the Ca2+/siRNA molar charge ratio was increased to
2.5/1.
In case of the lipid+siRNA mixtures (no calcium), as shown in
Table 1, the siRNA loading was 10% and 20% in mixtures prepared
with anionic lipid/siRNA molar charge ratios of 5/1 and 10/1, respec-
tively. When these mixtures were placed in media with serum, the
siRNA was entirely released within 4 h (Fig. 4d).
3.5. Silencing efﬁciency
3.5.1. Effect of liposome composition on silencing efﬁciency
Anionic lipoplexes (anionic lipid/Ca2+/siRNA molar charge ratio
of 5/2.5/1) prepared with different liposome compositions (mol%
DOPG) were evaluated for silencing efﬁciency in breast cancer cells.
As shown in Fig. 5a, the silencing efﬁciency signiﬁcantly increased
with increase in DOPG from 10 to 40 mol% DOPG. Thereafter, there
was no further increase in the knockdown efﬁciency.
3.5.2. Effect of Ca2+/siRNA molar charge ratio on silencing efﬁciency
When anionic lipoplexes (40 mol% DOPG, anionic lipid/siRNAmolar
charge ratio of 1.3/1) prepared with different Ca2+/siRNAmolar charge
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cantly more effective compared to Ca2+–siRNA complexes. Turbidity
was observed in media containing complexes prepared at Ca2+/siRNA
molar charge ratios≥5/1. Highly variable results were obtained with
Ca2+–siRNA complexes at all Ca2+/siRNA molar charge ratios investi-
gated. As per the results, maximum silencingwas obtainedwith anionic
lipoplexes prepared with a Ca2+/siRNA molar charge ratio of 2.5/1.
3.5.3. Effect of anionic lipid/siRNA molar charge ratio on silencing
efﬁciency
Anionic lipoplexes (40 mol% DOPG, Ca2+/siRNAmolar charge ratio
of 2.5/1) prepared with various anionic lipid/siRNA molar charge ra-
tios showed signiﬁcantly higher silencing with anionic lipoplexes
when compared to Ca2+–siRNA complexes from anionic lipid/siRNA
molar charge ratios of 0.06/1 to 1.3/1 (Fig. 5c). Further increase in an-
ionic lipid/siRNA molar charge ratios reduced the silencing efﬁciency.
Highly unstable lipoplexes were obtained at anionic lipid/siRNAmolar
charge ratiosb1.3/1.
4. Discussion
Anionic lipoplexes prepared with various liposome compositions
and anionic lipid/Ca2+/siRNA molar charge ratios were evaluated
for their physicochemical properties and silencing efﬁciency. It was
determined that the formulation parameters impacted the physico-
chemical attributes as well as the biological activity of anionic lipo-
plexes. Further, physicochemical studies facilitated interpretation of
structures formed by lipid–siRNA complexes prepared under various
formulation conditions.
4.1. Effect of formulation parameters on physiochemical characteristics
of anionic lipoplexes
Formulation parameters such as liposome composition noticeably
affected the physicochemical attributes of liposomes and lipoplexes.
For example, increase in the mol% DOPG increased the negative
charge of the liposomes due to increase in the proportion of the an-
ionic lipid (DOPG) (Fig. 2a). This increase in charge was accompanied
by a decrease in particle size (Fig. 1a). This is attributed to the greater
repulsion between the charged lipid head groups, which increases the
radius of curvature of the lipid bilayer resulting in smaller particles.
Although the lipoplex surface charge did increase with the mol%
DOPG (Fig. 2b), there was no signiﬁcant difference in their particle
size (Fig. 1b). This was probably due to the multiple events that
occur during lipoplex formation: (i) electrostatic interaction of the
anionic lipid (DOPG) with the siRNA via the calcium ions; and
(ii) lipid scrambling due to calcium induced fusion [36,37]. This series
of events results in large size particles and would obscure the rela-
tively small change in particle size of the participating liposomes.
This hypothesis is supported by the fact that the anionic lipoplexes
are approximately three times the size of the anionic liposomes
(Fig. 1a and b). Another reason for the lack of difference in lipoplex
particle size, irrespective of liposome composition, is the complimen-
tary role of the two lipids (DOPG, DOPE) in the process of lipoplex
formation.
Besides liposome composition, formulation parameters such as
the calcium/siRNA molar charge ratio also inﬂuenced the lipoplex
properties. For example, at a low Ca2+/siRNA molar charge ratio
(0.6/1), the lipoplex sizes were close to that of the liposomes (ca.
100 nm) (Fig. 1c). However, the size of the lipoplexes increased
with increase in the Ca2+/siRNA molar charge ratio (≥2.5/1). This
may be due to the presence of sub-optimal concentrations of calcium
at lower ratios, which may lead to inefﬁcient lipoplex formation. This
hypothesis is corroborated by the fact that these lipoplexes showed
poor siRNA loading (Fig. 3a) and the siRNA loading increased with in-
crease in the Ca2+/siRNA molar charge ratio reaching a maximum at2.5/1. In support of this, the particles had less negative charge at a low
Ca2+/siRNA molar charge ratio of 0.6/1 probably due to the presence
of the Ca2+ ions on the liposomal surfaces. At higher molar charge ra-
tios (2.5/1), calcium is sandwiched between the anionic lipids and
siRNA forming efﬁcient lipoplexes with higher negative charge. At
Ca2+/siRNA molar charge ratios>2.5/1, the surface charge was neu-
tralized to zero and further increased to a positive charge, due to
the extremely high concentrations of cationic Ca2+ ions (Fig. 2c).
Lipoplexes with Ca2+/siRNA molar charge ratios>2.5/1, all had sim-
ilar average size probably due to the limited availability of lipid and
siRNA to form larger aggregates.
The colloidal properties of the lipoplexes (particle size and surface
charge) were also affected by anionic lipid/siRNA molar charge ratios.
For example, at high lipid/siRNA molar charge ratios (≥5/1), large
particles (>500 nm) were formed (Fig. 1d). This increase in size
was probably due to aggregation mediated by excess lipid upon inter-
action with accessible Ca2+ ions that were not completely neutral-
ized during lipoplex formation. Interestingly, these particles (with
anionic lipid/siRNAmolar charge ratios of 5/1 to 40/1) showed no sig-
niﬁcant change in their zeta potential values (Fig. 2d). Theoretically,
surface charge should have increased with increase in the concentra-
tion of the anionic lipid, DOPG, and this held true for lipoplexes with
lower anionic lipid/siRNA molar charge ratios (b5/1). At higher ratios
(≥5/1), however, the lipoplexes aggregate in the presence of calcium
leading to partial surface charge neutralization. This aggregation was
conﬁrmed by particle size analysis (Fig. 1d). Very low lipid/siRNA ra-
tios (b1.3/1) formed unstable complexes due to the imbalance be-
tween the charge ratios of the formulation components. An anionic
lipid/siRNA ratio of 1.3/1 was therefore optimal.
In ternary anionic lipoplexes, calcium is the primary component
that complexes with the siRNA and the lipids. Therefore, as expected,
siRNA loading efﬁciency in the lipoplexes increased with increase in
concentration of calcium (Ca2+/siRNA molar charge ratio) (Fig. 3a). In-
terestingly, it was determined that lipids alone (no calcium) also con-
tributed to loading of the siRNA into the lipoplexes (Fig. 3c, Table 1).
This could be due to Van der Waal's attraction between the lipid
(DOPE) and siRNA as has been reported by others [30,38]. However,
even at themaximumanionic lipid/siRNAmolar charge ratio investigat-
ed, complete siRNA loading was not achieved probably due to satura-
tion of the lipid groups interacting with the siRNA. 100% siRNA
loading was achieved only with lipoplexes composed of a Ca2+/siRNA
molar charge ratio of 2.5/1, irrespective of the anionic lipid/siRNA
molar charge ratio. This indicates that lipids can only facilitate partial
loading and that calcium is required to achieve complete loading.
Serum is known to interfere with the transfection efﬁciency of the
cationic lipoplexes due to neutralization of the lipoplex charge by the
mostly anionic serum proteins [10,14,39]. In the case of Ca2+–siRNA
complexes, serumproteins competewith siRNA for binding to calcium
ions. If interaction between Ca2+ and siRNA is not sufﬁciently strong,
serummay cause siRNA to dissociate from the complexes. For this rea-
son, the serum stability of the Ca2+–siRNA complexeswas poor at low
Ca2+/siRNA molar charge ratios (Fig. 4a) while it improved with in-
crease in calcium (higher Ca2+/siRNA molar charge ratios) due to
the presence of optimal amounts of Ca2+ that could bind strongly to
the siRNA. Additionally, the presence of lipids in the complexes re-
duced the accessibility of Ca2+ to the serumproteins thereby prevent-
ing complex destabilization. This effect is evident from Fig. 4bwhere it
is shown that lipoplexes aremore stable than Ca2+–siRNA complexes.
With increase in lipid, the protection against serum dissociation im-
proved as indicated by Fig. 4c. Although lipids improved serum stabil-
ity, complete stability was achieved at a Ca2+/siRNA molar charge
ratio of 2.5/1 indicating the requirement of an adequate amount of cal-
cium to bind strongly with the siRNA and lipid thereby prohibiting
complex dissociation.
Physicochemical characterization of anionic lipoplexes has also
been useful in differentiating anionic lipoplexes from liposomes and
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and had lower surface charge due to partial charge neutralization
(Figs. 1b and 2b), when compared to the anionic liposomes (Figs. 1a
and 2a). Also, the lipoplex particles were monodisperse while the
Ca2+–siRNA complexes were polydisperse (Fig. 1e).
4.2. Effect of formulation parameters on the biological activity of
lipoplexes — correlation with physicochemical properties
The silencing efﬁciency can be explained on the basis of the phys-
icochemical properties of the complexes. For example, the large vari-
ation in the activity of the Ca2+–siRNA complexes (Fig. 5b) could be
due to the high polydispersity of these particles (Fig. 1e). In addition,
the lipid+siRNA mixtures dissociated in the serum (Fig. 4d) and
therefore showed no silencing in the cell culture studies (Fig. 5b). In
the case of lipoplexes, the low silencing efﬁciency at Ca2+/siRNA
molar charge ratiosb2.5/1 (Fig. 5b) was probably due to the inefﬁ-
cient siRNA loading as indicated in Fig. 3a. However, when investigat-
ed, lipoplexes with a Ca2+/siRNA molar charge ratio of 1.3/1, showed
high siRNA loading (80%). The reduced silencing efﬁciency of these
lipoplexes (Fig. 5b) was probably a result of lipoplex dissociation in
serum as indicated in Fig. 4b. For lipoplexes prepared with a Ca2+/
siRNA molar charge ratio of 0.6/1, the loading efﬁciency (in HEPES)
was negligible (Fig. 3a). However, these complexes did show some
knockdown effect (Fig. 5b). In order to understand this, the loading
efﬁciency of these complexes was evaluated in cell culture media
(Opti-MEM I) and was determined to be 60% (data not shown). The
higher siRNA loading in cell culture media compared to HEPES
could be due to the greater ionic strength of the former that may
have improved ionic interactions between lipid, Ca2+ and siRNA
in unstable anionic lipoplexes with unbalanced charge ratios (low
Ca2+ at Ca2+/siRNA ratio of 0.6/1). Even though the loading was im-
proved, these lipoplexes presumably destabilized in serum (very low
serum stability was observed with Ca2+/siRNA ratio of 0.9/1 in
Fig. 4b) leading to low silencing efﬁciency in breast cancer cells
(Fig. 5b). At the higher Ca2+/siRNA molar charge ratio of 2.5/1, max-
imum silencing efﬁciency of the lipoplexes was achieved (Fig. 5b).
This is considered to be due to efﬁcient loading (Fig. 3a) and complete
retention of loaded siRNA in the presence of serum (Fig. 4b). There-
fore, a Ca2+/siRNA molar charge ratio of 2.5/1 was optimal to prepare
stable (in serum) and efﬁcient lipoplexes. For lipoplexes prepared
with high Ca2+/siRNA molar charge ratios greater or equal to 5/1
(Fig. 5b) or high anionic lipid/siRNA molar charge ratios greater
than 5/1, (Fig. 5c) the silencing efﬁciency was low as a result of ex-
treme aggregation in the cell culture media. Consequently, the cellu-
lar uptake of these complexes was inefﬁcient [40–42]. These results
are in contrast to some reports that have indicated high biological ac-
tivity with large particles (micron range) [43,44].
The silencing efﬁciency of the lipoplexes preparedwith various lipo-
some compositions did not correlate with lipoplex particle size. The
lipoplexes prepared with various mol% DOPG were in same size but
showed increase in silencing efﬁciency with increase in mol% DOPG
(up to 40 mol%) (Figs. 1b and 5a). This indicates that the silencing efﬁ-
ciency is affected by the proportion of the lipids (DOPG, DOPE). DOPG is
an anionic lipid that facilitates lipoplex formation. DOPE is a fusogenic
lipid that undergoes phase transition from lamellar to inverted hexago-
nal phase at low endosomal pH, thereby causing endosome destabiliza-
tion and releasing the siRNA [45–48]. Consequently, increase in DOPG
promotes efﬁcient lipoplex formation thereby increasing siRNA loading
and hence increasing the silencing efﬁciency. On the other hand, in-
crease in DOPE facilitates the endosomal escape of siRNA and thereby
increases the silencing efﬁciency. Therefore, an optimal balance of
DOPG and DOPE results in maximum silencing.
In general, the particle properties correlated well with the biological
behavior of the anionic lipoplexes. Physicochemical characterization
studies also helped in understanding the role of the formulationcomponents on the biological activity. For example, lipids and Ca2+ co-
operatively contributed to siRNA loading (Fig. 3) and serum stability
(Fig. 4) and accordingly played a signiﬁcant role in enhancing the si-
lencing efﬁciency of the anionic lipoplexes. Additionally, systematic
physicochemical characterization facilitated estimation of the optimal
formulation (lipid/Ca2+/siRNAmolar charge ratio of 1.3/2.5/1) formax-
imum silencing efﬁciency.
4.3. Structure of siRNA-lipoplex assemblies and the proposed model
Within the lipoplexes, siRNA is associated with other formulation
components (lipids, Ca2+), based on the anionic lipid/siRNA molar
charge ratio. To understand this association, the percentage siRNA re-
leased from lipoplexes after the addition of either disodium EDTA or
disodium EDTA and TX-100 was determined. TX-100 is a nonionic
surfactant that solubilizes anionic liposomes and disodium EDTA is a
chelating agent that complexes with Ca2+ ions and releases siRNA.
The nature of the siRNA association can be determined as follows:
(i) complexed siRNA can be determined by the % siRNA released
from lipoplexes treated with EDTA alone, and (ii) complexed+
encapsulated siRNA can be determined by the % siRNA released
from lipoplexes treated with both EDTA and TX-100. The percentage
encapsulated siRNA can be calculated by subtraction of (i) from (ii).
As shown in Fig. 3b, in the absence of lipids (Ca2+–siRNA com-
plexes) or at low anionic lipid/siRNA molar charge ratios (≤1.3/1),
siRNA was completely (100%) released from the complexes, when
treated with EDTA alone (Fig. 3b). In addition, at these anionic lipid/
siRNA molar charge ratios, siRNA loading of anionic lipoplexes was
equivalent to that obtained with Ca2+–siRNA complexes (Fig. 3a and
b) whereas negligible loading was obtained in case of lipid+siRNA
mixtures (Fig. 3c). This indicates that at low anionic lipid/siRNA ratios
(b1.3/1), siRNA loading is only due to the Ca2+ via complexation and
there is no role of lipids in this process (represented in Fig. 6a). In
other words, siRNA is solely in the ‘complexed’ form within anionic
lipoplexes at low anionic lipid/siRNA ratios (b1.3/1) (represented in
Fig. 6a).
At high lipid/siRNA molar charge ratios (>5/1), loaded siRNA in
lipid+siRNA mixtures was released (unloaded) with TX100+EDTA,
but not with EDTA alone (Fig. 3c). This indicates that siRNA is solely
in the ‘encapsulated form’ within these complexes where the encap-
sulation occurs via Van der Waal's interaction between lipid (DOPE)
and siRNA. In anionic lipoplexes prepared at high anionic lipid/siRNA
ratios, % siRNA release with EDTA decreased with increase in lipid/
siRNA ratio, whereas 100% release was obtained with TX100+EDTA
at all lipid/siRNA ratios (Fig. 3b). This means that the proportion of
loaded siRNA in the ‘complexed’ form decreases and ‘encapsulated’
form increases with increase in lipid/siRNA ratio. Considering that
the amount of ‘encapsulated siRNA’ in anionic lipoplexes is equivalent
to the amount in lipid+siRNA mixtures at the same lipid/siRNA
ratio (Table 1), it can be concluded that ‘encapsulation’ is only due to
the lipids (DOPE) with no involvement of calcium (see ‘encapsulated
form’ in Fig. 6b). Therefore, it can be inferred that calcium primarily
contributes to siRNA complexation whereas lipids contribute to
siRNA encapsulation and both of these processes are required to
achieve complete siRNA loading. The characterization studies thus
revealed the synergistic role of lipids and Ca2+ in associating with
siRNA and forming the lipoplex assemblies.
It is clear that siRNA association within the lipoplexes depends on
the anionic lipid/siRNA molar charge ratios. Accordingly, lipoplexes
are in the ‘complexed’ form at low anionic lipid/siRNAmolar charge ra-
tios and in both the ‘complexed’ and ‘encapsulated’ forms at higher ra-
tios. Based on this conclusion, a schematic model representing anionic
lipoplex structures obtained using various anionic lipid/siRNA molar
charge ratios is proposed as shown in Fig. 6. Thismodel describes the ar-
rangement of lipid, Ca2+ and siRNAwithin the lipoplexes at low (0.06/
1–1.3/1) or high (≥5/1) anionic lipid/siRNA molar charge ratios. The
aEncapsulated form
Complexed form
Complexed form
b
Calcium ions
siRNA
Anionic liposomes
Fig. 6. Schematic representation of ternary anionic siRNA lipoplexes prepared with: (a) low anionic lipid/siRNA molar charge ratios (0.06/1 to 1.3/1) indicating the ‘complexed’
form; and (b) high anionic lipid/siRNA molar charge ratios (5/1 to 40/1) indicating both ‘encapsulated’ as well as ‘complexed’ forms. (ﬁxed Ca2+/siRNA molar charge ratio of
2.5/1).
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tios, has been discussed previously in the same Section 4.3. Fig. 6 also
shows that the optimal formulation (lipid/Ca2+/siRNA molar charge
ratio of 1.3/2.5/1), represented by Fig. 6a, has a slight excess of calcium
which is accessible even after complex formation. Calcium is a divalent
ion that electrostatically binds to the phosphate groups of the DOPG
lipid and of the siRNA. However, the complexation of calcium with
lipid and siRNA cannot be controlled stoichiometry. Additionally, the
model suggests steric hindrance preventing one to one interaction be-
tween lipid, calcium and the siRNA. Another reason could be the re-
quirement of excess calcium for efﬁcient cellular uptake of lipoplexes
via interaction with cell membrane proteoglycans.
According to Table 1, Figs. 3b and 5c, it can be observed that the ef-
ﬁciency of lipoplexes decreases with increase in the proportion of
siRNA in the encapsulated form speculating that lipoplexes in the
complexed form are more efﬁcient that the ones in the encapsulated
form. Encapsulation mainly occurred at high lipid/siRNA ratios
where the size of particles was observed to be large. Low efﬁciency
therefore could be attributed to this large size rather than their mor-
phology. Another reason for low silencing could be reduced availabil-
ity of Ca2+ as a result of the entrapment process. As speculated earlier,
Ca2+ could facilitate cellular uptake and hence improve the silencing
efﬁciency of the anionic lipoplexes. Encapsulation with excess lipids
(high lipid/siRNA ratios) resulted in formation of large particles prob-
ably due to the small size of siRNA and limited scope of condensation
after electrostatic interaction with other formulation components.
Both the complexed and encapsulated forms are represented by Fig. 6.
5. Conclusions
Physicochemical characterization of ternary anionic lipoplexes
composed of anionic liposomes, Ca2+ and siRNA prepared withvarious formulation parameters was performed. A good correlation
between physicochemical characteristics and biological activity of
the anionic lipoplexes was achieved that was utilized to estimate op-
timized formulations for efﬁcient siRNA delivery. The physicochemical
studies also helped in understanding the role of formulation compo-
nents (lipids, Ca2+) on the biological activity of the anionic lipoplexes.
The proposed model has helped understand the contributions of for-
mulation components towards the formation of lipid–siRNA complex
assemblies and the inﬂuence of various formulation conditions on
their morphology. To the best of our knowledge this is the ﬁrst time
that an elaborate systematic characterization study has been con-
ducted on a three-component system for siRNA delivery. Such well-
characterized delivery systems are very useful for rapid product opti-
mization as well as product consistency and therefore facilitate
economical siRNA product manufacturing on a commercial scale.Acknowledgements
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